Therapy safety differs in multimorbid patients

Brian Englund discusses the ORAL Surveillance findings showing differential safety of JAK versus TNF inhibitors.

Play episode from 29:09

Transcript

The AI-powered Podcast Player

Save insights by tapping your headphones, chat with episodes, discover the best highlights - and more!